Bio-Techne (TECH) Non-Current Assets (2009 - 2026)

Bio-Techne's (TECH) quarterly Non-Current Assets came in at $1.9 billion in Q1 2026, down 7.66% year-on-year from $2.0 billion in Q1 2025, and down 1.2% quarter-over-quarter from $1.9 billion in Q4 2025.

Bio-Techne (TECH) Non-Current Assets (2009 - 2026) Analysis & Trends

Bio-Techne's Non-Current Assets history runs 18 years deep, the most recent figure standing at $1.9 billion for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 7.66% year-over-year to $1.9 billion in Q1 2026; TTM through Mar 2026 was $7.6 billion, a 7.45% decrease from a year earlier, with the FY2025 full-year figure at $1.9 billion, down 6.56% from the prior year.
  • Non-Current Assets slipped to $1.9 billion in Q1 2026 per TECH's latest filing, from $1.9 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.2 billion in Q3 2023 and bottomed at $1.7 billion in Q2 2022.
  • The 5-year median for Non-Current Assets is $2.0 billion (2025), against an average of $2.0 billion.
  • Across the five-year window, Non-Current Assets increased 20.3% in 2023 and dropped 8.18% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $1.8 billion in 2022, then rose by 19.01% to $2.1 billion in 2023, then slipped by 4.87% to $2.0 billion in 2024, then dropped by 7.39% to $1.9 billion in 2025, then slipped by 1.2% to $1.9 billion in 2026.
  • Per Business Quant, the three latest TECH Non-Current Assets figures stand at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $1.9 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Bio-Techne 11.23 Bn 11.02 Bn 208.29 Mn 1.86 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.86 Bn
Dec 31, 2025 1.89 Bn
Sep 30, 2025 1.92 Bn
Jun 30, 2025 1.95 Bn
Mar 31, 2025 2.02 Bn
Dec 31, 2024 2.04 Bn
Sep 30, 2024 2.09 Bn
Jun 30, 2024 2.09 Bn
Mar 31, 2024 2.11 Bn
Dec 31, 2023 2.14 Bn
Sep 30, 2023 2.16 Bn
Jun 30, 2023 2.02 Bn
Mar 31, 2023 2.03 Bn
Dec 31, 2022 1.80 Bn
Sep 30, 2022 1.80 Bn
Jun 30, 2022 1.69 Bn
Mar 31, 2022 1.71 Bn
Dec 31, 2021 1.71 Bn
Sep 30, 2021 1.73 Bn
Jun 30, 2021 1.75 Bn